Dag Nord • 1959 • Sørumsand • 16 roles • 10 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
D DA-NO HOLDING AS	Managing Director/CEO	-	17,174,870	60 % directly
E ENDOTECH AS	Managing Director/CEO	133,009,994	21,587,837	20.52 % indirectly
E ET INNOVASJON AS	Managing Director/CEO	-	940,822	14.46 % indirectly
N NEORESQ AS	Managing Director/CEO	-	-26,185	10.58 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
D DA-NO HOLDING AS	Chairman	-	17,174,870	60 % directly
U UTHUSSETRA 9 AS Closed	Board Member	-	-163,964	30 % indirectly
N NORDIC MEDICAL GROUP AS Closed	Chairman	-	30,854,620	21.6 % indirectly
W WAMALINO GROUP AS Under liquidation	Board Member	4,675,257	24,947,389	21.6 % indirectly
E ENDOTECH INVEST AS Closed	Board Member	-	24,729	21 % indirectly
E ET INNOVASJON AS	Chairman	-	940,822	14.46 % indirectly
N NDS SECURITY AS Closed	Board Member	25,998,338	694,428	-
F FRIGGS ELDRE	Alternate Member	-	-	-
B BLAKER SAMFUNNSHUS BA	Board Member	-	-	-
S SAMEIET GRIMSTADGATA 11-15	Board Member	1,816,052	1,114,196	-
M MABSEMBALLASJE AS Closed	Chairman	13,504,197	90,000	-
B BLAKER UNGDOMSLAG	Chairman	-	-	-

Last update: Apr 30, 2026

Shares owned by Dag Nord

Name	Share class	Total operating income	Total equity	Share
D DA-NO HOLDING AS	B-aksjer Ordinære aksjer	0 0	17,174,870 17,174,870	10 % directly 60 % 50 % directly 60 %
U UTHUSSETRA 9 AS Closed		0	-163,964	30 % indirectly
N NORDIC MEDICAL GROUP AS Closed		0	30,854,620	21.6 % indirectly
W WAMALINO GROUP AS Under liquidation		4,675,257	24,947,389	21.6 % indirectly
E ENDOTECH INVEST AS Closed		0	24,729	21 % indirectly
E ENDOTECH AS		133,009,994	21,587,837	20.52 % indirectly
E ET INNOVASJON AS		0	940,822	14.46 % indirectly
N NEORESQ AS		0	-26,185	10.58 % indirectly
N NIKKIMED AS		0	15,551	5.4 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025